Seven Grand Managers, LLC Cin Cor Pharma, Inc. Transaction History

Seven Grand Managers, LLC

  • $739 Million
  • Q3 2025

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$19.9 - $38.94 $398,000 - $778,800
20,000 New
20,000 $656,000

About CinCor Pharma, Inc.

CINC Quotes by TradingView
  • Ticker CINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,764,300
  • Description
  • CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...
More about CINC
Track This Portfolio

Track Seven Grand Managers, LLC Portfolio

Follow Seven Grand Managers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Grand Managers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Seven Grand Managers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email